The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Mikhin V.P.

Kursk State Medical University

Kostina N.L.

Kursk State Medical University

Nikolenko T.A.

Kursk State Medical University

Savelyeva V.V.

Kursk State Medical University

Chernyatina M.A.

Kursk State Medical University

The possibilities of Mexidol in the complex therapy of arterial hypertension

Authors:

Mikhin V.P., Kostina N.L., Nikolenko T.A., Savelyeva V.V., Chernyatina M.A.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2024;17(5): 572‑580

DOI: 10.17116/kardio202417051572

Read: 1470 times

Download PDF (RU)
Contact the author
Table of contents

THE POSSIBILITIES OF MEXIDOL IN THE COMPLEX THERAPY OF ARTERIAL HYPERTENSION
THE POSSIBILITIES OF MEXIDOL IN THE COMPLEX THERAPY OF ARTERIAL HYPERTENSION

To cite this article:

Mikhin VP, Kostina NL, Nikolenko TA, Savelyeva VV, Chernyatina MA. The possibilities of Mexidol in the complex therapy of arterial hypertension. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;17(5):572‑580. (In Russ.)
https://doi.org/10.17116/kardio202417051572

 
ЭндоКард
Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Inte­rnational multicenter randomized double-blind placebo-controlled study asse­ssing the effi­cacy and safety of sequential therapy with Mexi­dol and Mexi­dol FORTE 250 in patients with chro­nic brain ischemia (MEMO): suba­nalysis in patients with arte­rial hype­rtension. Russian Journal of Preventive Medi­cine. 2024;(10):72-83
Morphofunctional and biochemical dete­rminants of endo­thelial function in patients with a new coro­navirus infe­ction COVID-19. Russian Journal of Preventive Medi­cine. 2024;(10):90-96
Modern approaches to diagnosis and treatment of syndrome of auto­nomic dysfunction in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11-2):66-75
Reso­lution of the expert council «Possibilities of neuroprotective therapy in patients with arte­rial hype­rtension and cognitive diso­rders». Russian Journal of Preventive Medi­cine. 2024;(11):85-93
The significance of exogenous nitrate and nitrite of plant origin for vascular health. Russian Journal of Preventive Medi­cine. 2024;(11):141-146
Alte­rations in the acti­vity of glutathione-dependent enzy­mes in erythrocytes of patients with acute pancreatitis of varying seve­rity. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):10-15
Cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):81-90
Predictors of Enga­gement and Active participation of Patients with Unco­ntrolled Hype­rtension in the Tele­health Surveillance Program. Russian Journal of Preventive Medi­cine. 2024;(12):37-43
Features of arte­rial blood flow velo­city characteristics in endo­thelial dysfunction. Russian Journal of Preventive Medi­cine. 2024;(12):100-106
The role of quantitative body composition analysis in popu­lation in the asse­ssment and moni­toring of cardiovascular risk meta­bolic factors. Russian Journal of Preventive Medi­cine. 2024;(12):128-134
Abstract:

A review of the literature is devoted to the effects of the ethylmethylhydroxypyridine succinate (mexidol) in patients with arterial hypertension. The analysis of 44 sources of Russian and foreign literature showed more effective achievement of the target values of blood pressure, prevention of severe complications in hypertensive crises in patients with mexidol therapy. The evidence of the positive effect of cytoprotective therapy on the condition of the left ventricle and vascular wall is considered. The results of large-scale studies demonstrating the effective correction of cognitive dysfunction of the brain using mexidol are presented. The role of the drug in stabilizing of biochemical processes, including lipid peroxidation, glucose and cholesterol metabolism, which determines the pleiotropic effects of mexidol in patients with hypertension, is emphasized.

Keywords:

arterial hypertension
vascular wall stiffness
lipid peroxidation
myocardial deremodelation
cognitive impairment

Authors:

Mikhin V.P.

Kursk State Medical University

Kostina N.L.

Kursk State Medical University

Nikolenko T.A.

Kursk State Medical University

Savelyeva V.V.

Kursk State Medical University

Chernyatina M.A.

Kursk State Medical University

Received:

03.07.2024

Accepted:

12.08.2024

Close metadata

References:

  1. Arterial hypertension in adults. Clinical guidelines 2020. Kobalava Zh.D., Konradi AO, Nedogoda SV, et al. Russian Journal of Cardiology. 2020;25(3):149-218. (In Russ.). https://doi.org/10.15829/1560-4071-2020-3-3786
  2. Balanova YuA, Drapkina OM, Kutsenko VA, et al. Hypertension in the Russian population during the COVID-19 pandemic: sex differences in prevalence, treatment and its effectiveness. Data from the ESSE-RF3 study. Cardiovascular Therapy and Prevention. 2023;22(8S):105-121. (In Russ.). https://doi.org/10.15829/1728-8800-2023-3785
  3. Muromtseva GA, Kontsevaya AV, Konstantinov VV, et al. The prevalence of non-infectious diseases risk factors In Russian population in 2012-2013 years. The results of ecvd-rf. Cardiovascular Therapy and Prevention. 2014;13(6):4-11. (In Russ.). https://doi.org/10.15829/1728-8800-2014-6-4-11
  4. Mancia G, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023 Dec 1;41(12):1874-2071. https://doi.org/10.1097/HJH.0000000000003480
  5. Bogolepova AN. The role of oxidative stress in the development of vascular cognitive disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(8):1-7. (In Russ.). https://doi.org/10.17116/jnevro2020120081133
  6. Martynov AI, Yun VL, Gorokhovskaya GN, et al. State of oxydative stress in hypertonic disease complicated by transitory ischemic attacks. Meditsinskiy sovet=medical council. 2016;(13):13-15. (In Russ.). https://doi.org/10.21518/2079-701x-2016-13-13-15
  7. Martínez-Revelles S, GarcíaRedondo AB, Avendaño MS, et al. Lysyl oxidase induces vascular oxidative stress and contributes to arterial stiffness and abnormal elastin structure in hypertension: role of p38MAPK. Antioxid. Redox Signal. 2017;27:379-397.  https://doi.org/10.1089/ars.2016.6642
  8. Shi X, Li P, Liu H, Prokosch V. Oxidative Stress, Vascular Endothelium, and the Pathology of Neurodegeneration in Retina. Antioxidants. 2022;11:543.  https://doi.org/10.3390/antiox11030/antiox11030543
  9. Grigorkevich OS, Mokrov GV, Kosova LYu. Matrix metalloproteinases and their inhibitors. Pharmacokinetics and Pharmacodynamics. 2019;(2):3-16. (In Russ.). https://doi.org/10.24411/2587-7836-2019-10040
  10. Iatskovskaia NM, Chirkin AA. Stress and vascular tonus: monography. Cheboksary: Sreda. 2023;112. (In Russ.).
  11. Astanina IA, Dudko VA, Vorozhtsova IN Carotid atherosclerosis detectability in patients with coronary heart diseaseand arterial hypertension. Terapevticheskii arkhiv. 2004;79(12):36-39. (In Russ.).
  12. Buvaltsev VI. Endothelial dysfunction as a new concept of prevention and treatment of cardiovascular diseases. International medical journal. 2001;3:202-209. (In Russ.).
  13. Schuchinger V, Fichtlscherer S, Brutten MB, Zeiher AM. Systemic nature of endothelial dysfunction between coronary and peripheral regulation of resistens vessels. European Heart Journal 1999; vol 20:653., Vanhoutte PM. Endothelial dysfunction and atherosclerosis. Europ Heart J. 1997;18:E19-E29. 
  14. Boitsov SA. What is new in information on hardness of the artery walls and on repulsed pulse wave? Ross Fiziol Zh Im I M Sechenova. 2009;95(5):516-531. PMID:19569528. (In Russ.).
  15. Lankin VZ, Tikhaze AK, Kosach VYa, et al. Modification of low-density lipoproteins by low molecular weight carbonyl products of free-radical oxidation of lipids and carbohydrates plays a key role in atherosclerotic lesion of the vascular wall and in endothelial dysfunction. Acta Biomedica Scientifica. 2023;8(3):14-24. (In Russ.). https://doi.org/10.29413/ABS.2023-8.3.2
  16. Tanashyan MM, Lagoda OV, Antonova KV. Cerebrovascular diseases: perspectives of pathogenetic metabolic haemangiocorrective treatment. S.S. Korsakov Journal of Neurology and Psychiatry. 2015;115(9):70-75. (In Russ.). https://doi.org/10.17116/jnevro20151159170-75
  17. Golikov AP, Lukyanov MM, Ryabinin VA, et al. Mexicor in the complex treatment and prevention of crises in patients with hypertension. Clinical studies of medicines In Russia. 2003;3-4:56-59. (In Russ.).
  18. Golikov AP, Lukjanov MM, Polumiskov VYu, et al. Hypertensive crises in patients with essential arterial hypertension and coronary heart disease: new perspectives in treatment and prevention. Cardiovascular Therapy and Prevention. 2005;4(3, I):10-16. (In Russ.).
  19. Nechaeva GI, Korennova OY, Bulakhova EY, et al. Optimization of treatment of arterial hypertension in young people with a burdened family history. RMJ. 2008;5:293. 10.29413/ABS.2023-8.3.2. (In Russ.).
  20. Shalashova ML, Dudaeva NG, Golovacheva TV. The use of Mexidol in combination therapy with traditional antihypertensive agents in patients with arterial hypertension with signs of chronic cerebral vascular insufficiency. Bulletin of Experimental Biology and medicine. 2006;1:152-155. (In Russ.).
  21. Khlebodarov FE, Mikhin VP. The effect of mildronate on endothelial function, daily blood pressure profile and intracardiac hemodynamics in patients with arterial hypertension. Kursk scientific and practical bulletin The Man and his health. 2009;2:125-129. (In Russ.).
  22. Tanashyan MM, Lagoda OV, Antonova KV. Chronic cerebrovascular diseases against the background of metabolic syndrome: new approaches to treatment. Journal of Neurology and Psychiatry. 2012;11:21-26. (In Russ.).
  23. Khlebodarov FE. Deremodeling of the cardiovascular system in patients with hypertension against the background of hypotensive and cardioprotective therapy: abstract of the dissertation of the Doctor of Medical sciences. Kursk; KSMU. 2010;48. (In Russ.).
  24. Khlebodarov FE, Mikhin VP, Ivanenko LN. The effectiveness of mexicor therapy in patients with hypertension. Journal «Terra medica nova». 2008;3:23-27. (In Russ.).
  25. Milyagina IV. Assessment of the balance of blood pressure and elastic properties of blood vessels in the clinic of internal diseases. Smolensk: Smolensk State Medical University. acad. 2008;142. (In Russ.).
  26. Mikhin VP, Boldyreva YA, Chernyatina MA, Gromnatsky NI. The state of vascular wall stiffness parameters in patients with arterial hypertension against the background of complex therapy with cytoprotectors and sartans. Archive of Internal Medicine. 2015;(5):40-44. (In Russ.). https://doi.org/10.20514/2226-6704-2015-0-5-15
  27. Khlebodarov FE, Mikhin VP. The effect of cardiocytoprotective therapy on the daily profile of blood pressure and remodeling of the heart and blood vessels in patients with hypertension. Kursk scientific and practical bulletin of «Man and his health». 2011;1:115-123. (In Russ.).
  28. Ostroumova OD, Chernyaeva MS. Arterial hypertension, cognitive impairment and dementia: a cardiologist’s view. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(9):117-125. (In Russ.). https://doi.org/10.17116/jnevro2018118091117
  29. Iadecola C, Yaffe K, Biller J, et al. Impact of hypertension on cognitive function: a scientific statement from the American Heart Association. Hypertension. 2016;68(6):e67-e94. 
  30. Stakhovskaya LV, Shamalov NA, Khasanova DR, et al. Results of a randomized double blind multicenter placebo-controlled, in parallel groups trial of the efficacy and safety of prolonged sequential therapy with mexidol in the acute and early recovery stages of hemispheric ischemic stroke (EPICA). S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(3-2):55-65. (In Russ.). https://doi.org/10.17116/jnevro20171173255-65
  31. Suslina ZA, Smirnova IN, Tanashyan MM, et al. Mexidol in chronic forms of cerebrovascular diseases. Treatment of nervous diseases. 2002;3(3):28-33. (In Russ.).
  32. Shchulkin AV. A modern concept of antihypoxic and antioxidant effects of mexidol. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(12-2):87-93. (In Russ.). https://doi.org/10.17116/jnevro201811812287
  33. Fedin AI, Zaharov VV, Tanashyan MM, et al. Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO). S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(11):7-16. (In Russ.). https://doi.org/10.17116/jnevro20211211117
  34. Martynov AI, Tanashyan MM, Malyavin AG, et al. Resolution of the Expert Council «Possibilities of neuroprotective therapy in patients with arterial hypertension and cognitive disorders». Therapy. 2023;(10):148-158. (In Russ.). https://dx.doi.org/10.18565/therapy.2023.10.148-158
  35. Mikhin VP, Grigorieva TA, Tsukanova YuA. Vascular endothelial dysfunction in patients with arterial hypertension on the background of diabetes mellitus and the possibility of its correction with Mexicor. Pharmateca. 2008;15:92-96. (In Russ.).
  36. Khlebodarov FE, Mikhin VP, Zabelina IV. The use of the drug Mexicor in patients with arterial hypertension. Terra Medica Nova. 2008;1(51):33-37. (In Russ.).
  37. Mikhin VP, Khlebodarov FE. Comparative evaluation of the efficacy of mexicor and trimetazidine in patients with hypertension against the background of therapy with angiotensin- converting enzyme inhibitors. Kursk scientific and practical bulletin «Man and his health». 2010;1:100-110. (In Russ.).
  38. Boytsov SA, Drapkina OM. Modern content and improvement of high cardiovascular risk strategy in reducing mortality from cardiovascular diseases. Ter Arkh. 2021;93(1):4-6. (In Russ.). https://doi.org/10.26442/00403660.2021.01.200543PMID:33720618
  39. Usov VYu, Plotnikov MP, Del OA, et al. Contrast-inhanced MRI of the aortic wall in the efficiency evaluation of ethylmethylhydroxypyridine succinate (Mexidol) long-term use to prevent aortic atherosclerosis progression. Bulletin of new medical technologies. 2018;25(1):125-132. (In Russ.). https://doi.org/10.24411/1609-2163-2018-15973
  40. Egorov IV. Modern approaches to antioxidant support for patients with cardiovascular pathology. Journal of Polyclinics. 2008;2:60-63. (In Russ.).
  41. Shchepankevich LA, Tanashyan MM, Nikolaev YuA, et al. Role of antioxidants in treatment and prevention of patients with high risk of cardiovascular complications. Russian Journal of Cardiology and Cardiovascular Surgery. 2018;11(4):31-35. (In Russ.). https://doi.org/10.17116/kardio201811431
  42. Abramenko YuV. The efficacy of mexidol for transient ischemic attacks in the vertebrobasilar system in elderly patients with chronic cerebral ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(9-2):42-48. (In Russ.). https://doi.org/10.17116/jnevro201811809242
  43. Martynov MU, Zhuravleva MV, Vasyukova NS, et al. Oxidative stress in the pathogenesis of stroke and its correction. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(1):16-27. (In Russ.). https://doi.org/10.17116/jnevro202312301116
  44. Smirnova IN, Fedorova TN, Tanashyan MM, Suslina ZA. Clinical efficacy and antioxidant activity of Mexidol in chronic cerebrovascular diseases. Atmosphere. Nervous diseases. 2006;1:33-36. (In Russ.).
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.